Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211912 · ClinicalTrials.gov registry record · Phase 1
Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT01211912: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01211912 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01211912, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study has two aims: 1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients) 2. to understand the impact of maternal acetaminophen use on fetal movement and breathing (20 patients)
Interventions
- DRUG Arm 1 (20 patients)
- DRUG Arm 2 (34 patients)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01211912
The ClinicalTrials.gov registry entry for NCT01211912 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arm 1 (20 patients) is the first listed.
NCT01211912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01211912 about?
NCT01211912 is a clinical study titled "Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being". This study has two aims: 1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients) 2. to understand the impact of maternal acetaminophen use on fetal movement and breathing (20 patients)
What is the current status of trial NCT01211912?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2010-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01211912?
The interventions under investigation include: Arm 1 (20 patients) (DRUG), Arm 2 (34 patients) (DRUG).
Who is sponsoring clinical trial NCT01211912?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.